Aura Biosciences (AURA) Total Non-Current Liabilities (2020 - 2022)

Aura Biosciences' Total Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $5.9 million for Q2 2022.

• Quarterly Total Non-Current Liabilities changed N/A year-over-year to $5.9 million in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $5.9 million (changed N/A YoY) and the FY2021 annual result came in at $7.6 million, up 185.95% from the prior year.
• Total Non-Current Liabilities was $5.9 million for Q2 2022 at Aura Biosciences, up from $5.2 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $7.6 million in Q4 2021 and bottomed at $2.7 million in Q4 2020.
• A 3-year average of $5.5 million and a median of $5.9 million in 2022 frame the typical range for Total Non-Current Liabilities.
• Peak annual rise in Total Non-Current Liabilities reached 185.95% in 2021, while the deepest fall reached 185.95% in 2021.
• Aura Biosciences' Total Non-Current Liabilities stood at $2.7 million in 2020, then jumped by 185.95% to $7.6 million in 2021, then declined by 23.18% to $5.9 million in 2022.
• Business Quant data shows AURA's Total Non-Current Liabilities at $5.9 million in Q2 2022, $5.2 million in Q1 2022, and $7.6 million in Q4 2021.